TY  - GEN
AU  - Nallamothu,Brahmajee K
AU  - Bates,Eric R
AU  - Hochman,Judith S
AU  - Granger,Christopher B
AU  - Guetta,Victor
AU  - Wilcox,Robert G
AU  - White,Harvey D
AU  - Armstrong,Paul W
AU  - Savonitto,Stefano
AU  - Jia,Gang
AU  - Lincoff,A Michael
AU  - Topol,Eric J
TI  - Prognostic implication of activated partial thromboplastin time after reteplase or half-dose reteplase plus abciximab: results from the GUSTO-V trial
SN  - 0195-668X
PY  - 2005///1020
KW  - Abciximab
KW  - Adult
KW  - Aged
KW  - Angina Pectoris
KW  - drug therapy
KW  - Antibodies, Monoclonal
KW  - administration & dosage
KW  - Anticoagulants
KW  - Bundle-Branch Block
KW  - Coronary Restenosis
KW  - etiology
KW  - Coronary Stenosis
KW  - Drug Therapy, Combination
KW  - Female
KW  - Fibrinolytic Agents
KW  - Hemorrhage
KW  - chemically induced
KW  - Humans
KW  - Immunoglobulin Fab Fragments
KW  - Injections, Intravenous
KW  - Male
KW  - Middle Aged
KW  - Myocardial Infarction
KW  - Partial Thromboplastin Time
KW  - mortality
KW  - Recombinant Proteins
KW  - Recurrence
KW  - Regression Analysis
KW  - Survival Analysis
KW  - Tissue Plasminogen Activator
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1093/eurheartj/ehi181
ER  -